Cost-utility of vitamin D supplementation to prevent acute respiratory infections in children

ABSTRACT: Introduction: Increasing evidence has demonstrated the effectiveness and safety of vitamin D supplementation to prevent acute respiratory infections in children. More economic evaluations incorporating the new evidence and in the pediatric population are needed to know the efficiency of th...

Full description

Autores:
Buendía Rodríguez, Jefferson Antonio
Guerrero Patiño, Diana
Tipo de recurso:
Article of investigation
Fecha de publicación:
2023
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/45377
Acceso en línea:
https://hdl.handle.net/10495/45377
Palabra clave:
Niño
Child
Análisis Costo-Beneficio
Cost-Benefit Analysis
Colombia
Infecciones del Tracto Respiratorio
Respiratory Tract Infections
Economía y Organizaciones para la Atención de la Salud
Health Care Economics and Organizations
Corticoesteroides
Adrenal Cortex Hormones
Vitamina D
Vitamin D
https://id.nlm.nih.gov/mesh/D002648
https://id.nlm.nih.gov/mesh/D003362
https://id.nlm.nih.gov/mesh/D003105
http://id.nlm.nih.gov/mesh/D012141
https://id.nlm.nih.gov/mesh/D004472
https://id.nlm.nih.gov/mesh/D000305
https://id.nlm.nih.gov/mesh/D014807
Rights
openAccess
License
http://creativecommons.org/licenses/by/2.5/co/
Description
Summary:ABSTRACT: Introduction: Increasing evidence has demonstrated the effectiveness and safety of vitamin D supplementation to prevent acute respiratory infections in children. More economic evaluations incorporating the new evidence and in the pediatric population are needed to know the efficiency of this treatment. This study aimed to determine the cost-utility of vitamin D supplementation to prevent acute respiratory infections in pediatric patients. Methods: A decision tree model was used to estimate the cost and quality-adjusted life-years (QALYs) of vitamin D supplementation in healthy school children between 1 and 16 years. Multiple sensitivity analyses were conducted. Cost-effectiveness was evaluated at a willingness-to-pay (WTP) value of $19,000. Results: The base-case analysis showed that vitamin D supplementation was associated with lower costs and higher QALYs than strategy without this supplementation. The QALYs per person estimated in the model for those treatments were 0,99 with vitamin D supplementation and 0,98 without vitamin D supplementation. The total costs per person were US$ 1354 for vitamin D supplementation and US$ 1948 without vitamin D supplementation. This position of absolute dominance of vitamin D supplementation makes it unnecessary to estimate the incremental cost-effectiveness ratio. Conclusion: In conclusion, our study shows that Vitamin D supplementation is a cost-effective strategy to prevent ARI in pediatric patients, from a societal perspective.